摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5,11,17,23-tetra-tert-butyl-25-(3-bromopropyloxy)-27-(3-nalidixoylpropyloxy)-26,28-dihydroxycalix[4]arene | 1352929-05-5

中文名称
——
中文别名
——
英文名称
5,11,17,23-tetra-tert-butyl-25-(3-bromopropyloxy)-27-(3-nalidixoylpropyloxy)-26,28-dihydroxycalix[4]arene
英文别名
——
5,11,17,23-tetra-tert-butyl-25-(3-bromopropyloxy)-27-(3-nalidixoylpropyloxy)-26,28-dihydroxycalix[4]arene化学式
CAS
1352929-05-5
化学式
C62H77BrN2O7
mdl
——
分子量
1042.21
InChiKey
XBJUVVUNLFWHQA-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    13.79
  • 重原子数:
    72.0
  • 可旋转键数:
    11.0
  • 环数:
    7.0
  • sp3杂化的碳原子比例:
    0.47
  • 拓扑面积:
    120.11
  • 氢给体数:
    2.0
  • 氢受体数:
    9.0

反应信息

  • 作为反应物:
    描述:
    5,11,17,23-tetra-tert-butyl-25-(3-bromopropyloxy)-27-(3-nalidixoylpropyloxy)-26,28-dihydroxycalix[4]arenepenicillin V potassiumN,N-二甲基甲酰胺 为溶剂, 反应 48.0h, 以73%的产率得到3-[[5,11,17,23-tetratert-butyl-27-[3-(1-ethyl-7-methyl-4-oxo-1,8-naphthyridine-3-carbonyl)oxypropoxy]-26,28-dihydroxy-25-pentacyclo[19.3.1.13,7.19,13.115,19]octacosa-1(24),3,5,7(28),9,11,13(27),15(26),16,18,21(25),22-dodecaenyl]oxy]propyl (2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(2-phenoxyacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
    参考文献:
    名称:
    Molecular drug-organiser: Synthesis, characterization and biological evaluation of penicillin V and/or nalidixic acid calixarene-based podands
    摘要:
    Two well-known antibiotic heterocycles, the 'quinolone' nalidixic acid and the beta-lactam penicillin V, active at different levels of the bacterial growth process, have been attached via an ether-ester junction to the p-tert-butylcalix[4] arene lower rim, in alternate position. The resulting hydrophobic molecular drug-organisers were fully characterized, and evaluated over two Gram negative and three Gram positive reference strains, using disk diffusion assays with disks impregnated with solution of title compound in pure DMSO. An interesting activity was observed over Staphylococcus aureus ATCC 25923 with the dissymmetrical podand incorporating one penicillin and one nalidixic ester moieties. (C) 2011 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2011.10.031
  • 作为产物:
    描述:
    5,11,17,23-tetra-tert-butyl-25-(3-bromopropyloxy)-26,27,28-trihydroxycalix[4]arene 、 bromopropyl nalidixate 在 potassium carbonate 作用下, 以 乙腈 为溶剂, 反应 48.5h, 以20%的产率得到5,11,17,23-tetra-tert-butyl-25-(3-bromopropyloxy)-27-(3-nalidixoylpropyloxy)-26,28-dihydroxycalix[4]arene
    参考文献:
    名称:
    Molecular drug-organiser: Synthesis, characterization and biological evaluation of penicillin V and/or nalidixic acid calixarene-based podands
    摘要:
    Two well-known antibiotic heterocycles, the 'quinolone' nalidixic acid and the beta-lactam penicillin V, active at different levels of the bacterial growth process, have been attached via an ether-ester junction to the p-tert-butylcalix[4] arene lower rim, in alternate position. The resulting hydrophobic molecular drug-organisers were fully characterized, and evaluated over two Gram negative and three Gram positive reference strains, using disk diffusion assays with disks impregnated with solution of title compound in pure DMSO. An interesting activity was observed over Staphylococcus aureus ATCC 25923 with the dissymmetrical podand incorporating one penicillin and one nalidixic ester moieties. (C) 2011 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2011.10.031
点击查看最新优质反应信息